The Beauty Health Company (NASDAQ:SKIN) Stock Has Consensus Target Price of $18.00

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned an average rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $18.00.

SKIN has been the topic of a number of research reports. Canaccord Genuity Group set a $11.00 price objective on shares of Beauty Health and gave the stock a “hold” rating in a research report on Thursday, October 22nd. Stifel Nicolaus set a $10.00 price target on shares of Beauty Health in a research report on Thursday, October 15th. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. Weiss Ratings reissued a “sell (e+)” rating on shares of Beauty Health in a research report on Wednesday, October 21st. Finally, TD Cowen started coverage on Beauty Health in a research note on Friday. They issued a “hold” rating for the company.

Beauty Health Price Performance

Shares of NASDAQ SKIN opened at $9.94 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.48 and a debt-to-equity ratio of 4.36. The firm has a market capitalization of $64.71 million, a PE ratio of -2.26 and a beta of 1.05. The firm’s 50-day moving average is $12.48 and its 200-day moving average is $16.85. Beauty Health has a 1 year low of $9.68 and a 1 year high of $34.80.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.50) by $0.10. The firm had revenue of $72.11 million for the quarter, compared to analysts’ expectations of $74.45 million. Beauty Health had a negative return on equity of 47.83% and a negative net margin of 9.79%. Equities analysts expect that Beauty Health will post -3.18 EPS for the current year.

Hedge Funds Weigh In On Beauty Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Bank of America Corp DE lifted its stake in Beauty Health by 19.2% in the 1st quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock valued at $95,000 after purchasing an additional 17,088 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Beauty Health by 29.6% during the 1st quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after acquiring an additional 64,900 shares in the last quarter. Finally, Capricorn Fund Managers Ltd bought a new stake in Beauty Health during the 1st quarter worth $17,270,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.